Understanding how DPEP1 interacts with immune cells in CRC and how it relates to overall tumor phenotypes such as microsatellite status might expose a therapeutic vulnerability to overcome resistance of MSS CRC to ICI. The gene discussed is DPEP1; the disease is neoplasm.